全文获取类型
收费全文 | 4551篇 |
免费 | 322篇 |
国内免费 | 26篇 |
专业分类
耳鼻咽喉 | 76篇 |
儿科学 | 147篇 |
妇产科学 | 96篇 |
基础医学 | 807篇 |
口腔科学 | 146篇 |
临床医学 | 443篇 |
内科学 | 797篇 |
皮肤病学 | 93篇 |
神经病学 | 646篇 |
特种医学 | 120篇 |
外科学 | 386篇 |
综合类 | 26篇 |
一般理论 | 2篇 |
预防医学 | 306篇 |
眼科学 | 180篇 |
药学 | 281篇 |
中国医学 | 23篇 |
肿瘤学 | 324篇 |
出版年
2023年 | 39篇 |
2022年 | 25篇 |
2021年 | 68篇 |
2020年 | 76篇 |
2019年 | 104篇 |
2018年 | 95篇 |
2017年 | 120篇 |
2016年 | 118篇 |
2015年 | 134篇 |
2014年 | 140篇 |
2013年 | 228篇 |
2012年 | 386篇 |
2011年 | 354篇 |
2010年 | 213篇 |
2009年 | 207篇 |
2008年 | 322篇 |
2007年 | 359篇 |
2006年 | 323篇 |
2005年 | 296篇 |
2004年 | 308篇 |
2003年 | 270篇 |
2002年 | 258篇 |
2001年 | 42篇 |
2000年 | 25篇 |
1999年 | 50篇 |
1998年 | 54篇 |
1997年 | 43篇 |
1996年 | 33篇 |
1995年 | 22篇 |
1994年 | 21篇 |
1993年 | 17篇 |
1992年 | 11篇 |
1991年 | 18篇 |
1990年 | 9篇 |
1989年 | 12篇 |
1988年 | 7篇 |
1987年 | 10篇 |
1986年 | 6篇 |
1985年 | 8篇 |
1984年 | 7篇 |
1983年 | 7篇 |
1982年 | 5篇 |
1981年 | 7篇 |
1980年 | 6篇 |
1978年 | 9篇 |
1977年 | 4篇 |
1976年 | 3篇 |
1974年 | 3篇 |
1963年 | 2篇 |
1961年 | 2篇 |
排序方式: 共有4899条查询结果,搜索用时 22 毫秒
1.
Laurien J. Zeverijn Eleonora J. Looze Subotheni Thavaneswaran J. Maxime van Berge Henegouwen Robert J. Simes Louisa R. Hoes Katrin M. Sjoquist Hanneke van der Wijngaart Lucille Sebastian Birgit S. Geurts Chee K. Lee Gijsbrecht F. de Wit David Espinoza Paul Roepman Frank P. Lin Anne M. L. Jansen Wendy W. J. de Leng Vincent van der Noort Lindsay V. M. Leek Filip Y. F. L. de Vos Carla M. L. van Herpen Hans Gelderblom Henk M. W. Verheul David M. Thomas Emile E. Voest 《International journal of cancer. Journal international du cancer》2023,153(7):1413-1422
The Dutch Drug Rediscovery Protocol (DRUP) and the Australian Cancer Molecular Screening and Therapeutic (MoST) Program are similar nonrandomized, multidrug, pan-cancer trial platforms that aim to identify signals of clinical activity of molecularly matched targeted therapies or immunotherapies outside their approved indications. Here, we report results for advanced or metastatic cancer patients with tumors harboring cyclin D-CDK4/6 pathway alterations treated with CDK4/6 inhibitors palbociclib or ribociclib. We included adult patients that had therapy-refractory solid malignancies with the following alterations: amplifications of CDK4, CDK6, CCND1, CCND2 or CCND3, or complete loss of CDKN2A or SMARCA4. Within MoST, all patients were treated with palbociclib, whereas in DRUP, palbociclib and ribociclib were assigned to different cohorts (defined by tumor type and alteration). The primary endpoint for this combined analysis was clinical benefit, defined as confirmed objective response or stable disease ≥16 weeks. We treated 139 patients with a broad variety of tumor types; 116 with palbociclib and 23 with ribociclib. In 112 evaluable patients, the objective response rate was 0% and clinical benefit rate at 16 weeks was 15%. Median progression-free survival was 4 months (95% CI: 3-5 months), and median overall survival 5 months (95% CI: 4-6 months). In conclusion, only limited clinical activity of palbociclib and ribociclib monotherapy in patients with pretreated cancers harboring cyclin D-CDK4/6 pathway alterations was observed. Our findings indicate that monotherapy use of palbociclib or ribociclib is not recommended and that merging data of two similar precision oncology trials is feasible. 相似文献
2.
Wessel Theda Heuing Katharina Schlangen Miriam Schnieders Birgit Algermissen Markus 《Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz》2022,65(11):1119-1125
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz - Menschen mit Seltenen Erkrankungen stehen im Gesundheitssystem vor besonderen Herausforderungen. Die Seltenheit der einzelnen... 相似文献
3.
Torture victims often show symptoms of dental anxiety when receiving dental care, but little systematic research is available. The purpose of this study was to explore torture experiences, symptoms of post‐traumatic stress disorder (PTSD), and dental anxiety in refugees in Norway and to test the hypothesis that refugees with torture experiences are more prone to dental anxiety than refugees with no such experiences. A total of 173 refugees were interviewed shortly after an oral examination. The Modified Dental Anxiety Scale (MDAS) and the Harvard Trauma Questionnaire‐PTSS16 were administered verbally through attending interpreters. Among torture victims (47%, n = 81), the prevalence of torture experiences involving mouth or teeth was 35% and 23%, respectively. Harvard Trauma Questionnaire mean sum scores were statistically significantly higher in torture victims (34.3 vs. 24.8). Torture survivors report a larger number of symptoms of PTSD, and dental anxiety shows a higher prevalence in refugees reporting PTSD symptoms than in refugees who do not report such symptoms. When analysed using logistic regression models, the data showed the odds of high levels of dental anxiety being 6.1 times higher in refugees with torture experiences compared with other refugees and 9.3 times higher in torture victims with PTSD symptoms. Oral health professionals should be aware of these associations when providing dental care to refugees. The hypothesis that tortured refugees are more prone to dental anxiety is supported. 相似文献
4.
5.
6.
7.
Nightmare disorder and recurrent isolated sleep paralysis are rapid eye movement (REM) parasomnias that cause significant distress to those who suffer from them. Nightmare disorder can cause insomnia due to fear of falling asleep through dread of nightmare occurrence. Hyperarousal and impaired fear extinction are involved in nightmare generation, as well as brain areas involved in emotion regulation. Nightmare disorder is particularly frequent in psychiatric disorders and posttraumatic stress disorder. Nonmedication treatment, in particular imagery rehearsal therapy, is especially effective. Isolated sleep paralysis is experienced at least once by up to 40% of the general population, whereas recurrence is less frequent. Isolated sleep paralysis can be accompanied by very intense and vivid hallucinations. Sleep paralysis represents a dissociated state, with persistence of REM atonia into wakefulness. Variations in circadian rhythm genes might be involved in their pathogenesis. Predisposing factors include sleep deprivation, irregular sleep–wake schedules, and jetlag. The most effective therapy consists of avoiding those factors.Supplementary InformationThe online version contains supplementary material available at 10.1007/s13311-020-00966-8.Key Words: Dream, REM sleep, REM muscle atonia, polysomnography, parasomnia, REM sleep behavior disorder. 相似文献
8.
9.